+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Intragastric Balloon Market (2021-2027) by Type, Administration, Filling Material, Implanting Procedure, Application, End-User, and Geography. IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • PDF Icon

    Report

  • 185 Pages
  • August 2021
  • Region: Global
  • Infogence Global Research
  • ID: 5451296
UP TO OFF until Nov 30th 2022
The Global Intragastric Balloon Market is estimated to be USD 36.15 Mn in 2021 and is expected to reach USD 73.29 Mn by 2027, growing at a CAGR of 12.5%.



Market Dynamics


Key factors such as the growing obesity-related disorders such as the rise in co-morbidities associated with obesity and sedentary lifestyle have been a prominent driver for the intragastric balloon market. Moreover, the rising demand for minimally invasive surgery is further attributed to the growth of the market.

However, the side effects such as nausea, vomiting, stomach cramps, acid reflux etc associated with the procedure and stringent product approval norms are restraining the growth of the market.

Market Segmentation


The Global Intragastric Balloon Market is segmented further based on Type, Administration, Filling Material, Implanting Procedure, Application, End-User, and Geography.

By Type, the market is classified as single, dual, and triple. Amongst all, the single segment is estimated to hold the highest market share

By Administration, the market is classified as Pill form and Endoscopy. Amongst all, the endoscopy segment is estimated to hold the highest market share.

By Filling Material, the market is classified as Saline Filled and Gas Filled. Amongst the two, the saline-filled segment is estimated to hold the highest market share.

By Implanting procedure, the market is classified as Surgical, Non-Surgical, and others. Amongst all the non-surgical segment is estimated to hold the highest market share.

By Application, the market is classified as Obesity, Diabetes, Diet Control, Weight-loss, Pre-operative Weight Reduction, and others. Amongst all, the obesity segment is estimated to hold the highest market share.

By End User, the market is classified as Hospitals, Ambulatory Surgical Centers, and clinics. Amongst all, the hospital segment is estimated to hold the highest market share.

By Geography, North America is projected to lead the market.

Recent Developments

1. Allurion Technologies has launched the Allurion Program that features the Elipse Balloon, the world’s only procedure less weight loss device. The balloon is monitored in the stomach for 4 months via a Bluetooth connected scale, an Allurion smartphone app, and a supervised nutritional program. 10th November 2020
2. Obalon Therapeutics and ReShape have merged and the new company shall be named as renamed as ReShape Lifesciences. - 20th January 2021

Company Profiles

Some of the companies covered in this report are Apollo Endosurgery, Spatz Medical, Allurion, Medsil, Medicone, Silimed, Endalis and Districlass among others.

Competitive Quadrant

The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Intragastric Balloon Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.

  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes in-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.

  • The report also contains the competitive analysis using the Competitive Quadrant, the publisher’s proprietary competitive positioning tool.


Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Intragastric Balloon Market

What is the estimated value of the Global Intragastric Balloon Market?

The Global Intragastric Balloon Market was estimated to be valued at $36.15 Million in 2021.

What is the growth rate of the Global Intragastric Balloon Market?

The growth rate of the Global Intragastric Balloon Market is 12.5%, with an estimated value of $73.29 Million by 2027.

What is the forecasted size of the Global Intragastric Balloon Market?

The Global Intragastric Balloon Market is estimated to be worth $73.29 Million by 2027.

Who are the key companies in the Global Intragastric Balloon Market?

Key companies in the Global Intragastric Balloon Market include Apollo Endosurgery, Inc., ReShape Lifesciences Inc, Allurion Technologies, Inc, Spatz FGIA Inc, Helioscopie Medical Implants, Endalis, Medsil, Lexel Medical and Districlass Medical SA.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
4 Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Growing obesity-related disorders
4.2.1.2 Rise in the demand for minimally invasive surgeries
4.2.2 Restraints
4.2.2.1 Stringent product approvals procedure
4.2.2.2 Side effects associated with the surgery
4.2.3 Opportunities
4.2.3.1 Availability of cost-efficient treatments for weight loss
4.2.3.2 Developments taking place in the intragastric balloon market
4.2.4 Challenges
4.2.4.1 Complications associated with gastric balloons
4.3 Trends
5 Market Analysis
5.1 Porter’s Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis
6 Global Intragastric Balloon Market, By Type
6.1 Introduction
6.2 Single
6.3 Dual
6.4 Triple
7 Global Intragastric Balloon Market, By Filling Material
7.1 Introduction
7.2 Saline Filled
7.3 Gas Filled
8 Global Intragastric Balloon Market, By Administration
8.1 Introduction
8.2 Pill form
8.3 Endoscopy
9 Global Intragastric Balloon Market, By Implanting Procedure
9.1 Introduction
9.2 Surgical
9.3 Non-Surgical
9.3.1 Oral Pill
9.3.2 Endoscopic Placement
9.4 Others
10 Global Intragastric Balloon Market, By Application area
10.1 Introduction
10.2 Obesity
10.3 Diabetes
10.4 Diet Control
10.5 Weight-loss
10.6 Pre-operative Weight Reduction
10.7 Others
11 Global Intragastric Balloon Market, By End User
11.1 Introduction
11.2 Hospitals
11.3 Ambulatory Surgical Centers
11.4 Clinics
12 Global Intragastric Balloon Market, By Geography
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 South America
12.3.1 Brazil
12.3.2 Argentina
12.4 Europe
12.4.1 UK
12.4.2 France
12.4.3 Germany
12.4.4 Italy
12.4.5 Spain
12.4.6 Rest of Europe
12.5 Asia-Pacific
12.5.1 China
12.5.2 Japan
12.5.3 India
12.5.4 Indonesia
12.5.5 Malaysia
12.5.6 South Korea
12.5.7 Australia
12.5.8 Russia
12.5.9 Rest of APAC
12.6 Rest of the World
12.6.1 Qatar
12.6.2 Saudi Arabia
12.6.3 South Africa
12.6.4 United Arab Emirates
12.6.5 Latin America
13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Competitive Scenario
13.3.1 Mergers & Acquisitions
13.3.2 Agreement, Collaborations, & Partnerships
13.3.3 New Product Launches & Enhancements
13.3.4 Investments & Funding
14 Company Profiles
14.1 Apollo Endosurgery, Inc.
14.2 ReShape Lifesciences Inc
14.3 Allurion Technologies, Inc
14.4 Spatz FGIA Inc
14.5 Helioscopie Medical Implants
14.6 Endalis
14.7 Medsil
14.8 Lexel Medical
14.9 Sientra, Inc.
14.10 Districlass Medical SA
14.11 Silimed Duomed Group (Life Partners Europe)
14.12 Aspire Bariatrics Inc
14.13 Baronova Inc
14.14 Allergan Inc
14.15 Districlass Medical
14.16 Tulip Medical
14.17 Medtronic
14.18 Shandong Institute of Medical Instruments
14.19 Halex Istar Indústria Farmacêutica Ltda (Medicone)
14.20 Fengh Medical
14.21 Phagia Technologies
14.22 PlenSat
15 Appendix
15.1 Questionnaire

Companies Mentioned

  • Apollo Endosurgery, Inc.
  • ReShape Lifesciences Inc
  • Allurion Technologies, Inc
  • Spatz FGIA Inc
  • Helioscopie Medical Implants
  • Endalis
  • Medsil
  • Lexel Medical
  • Sientra, Inc.
  • Districlass Medical SA
  • Silimed Duomed Group (Life Partners Europe)
  • Aspire Bariatrics Inc
  • Baronova Inc
  • Allergan Inc
  • Districlass Medical
  • Tulip Medical
  • Medtronic
  • Shandong Institute of Medical Instruments
  • Halex Istar Indústria Farmacêutica Ltda (Medicone)
  • Fengh Medical
  • Phagia Technologies
  • PlenSat